Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
Status:
Not yet recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
The goal of this observational study or clinical trial is to learn about the effect of
neutrophil gelatinase-associated lipocalin (NGAL) on vascular calcification in maintenance
hemodialysis patients with secondary hyperparathyroidism (SHPT). The main question it aims to
answer is: the predictive effects of blood NGAL level on the efficacy of palicalcitol in the
treatment of SHPT and the adverse reactions of vascular calcification progression.
Participants will be treated with palicalcitol, followed up and undergo routine series of
Chronic Kidney Disease-Mineral and Bone Disorder associated tests before and after treatment.